The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022 Journal of Pharmaceutical Innovation Springer Nature Link Compounded "semaglutide" is not FDA approved semaglutide.com Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law